TNF and ulcerative colitis: In trials of acute inflammation, such as steroid-refractory and severe ulcerative colitis (UC), anti-TNF agents were shown to have a favorable adverse event profile, in addition to inducing higher remission rates and improving the percentage of colon-salvage [5-7].